Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
ALBANY, N.Y., Sept. 13, 2017 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C. Greiner, Executive Vice President and Chief Financial Officer, is scheduled to present at the 2017 Cantor Fitzgerald Healthcare Conference on Monday, September 25, 2017, at 8:35 a.m. EDT. The conference will be held at the InterContinental New York Barclay in New York City.
A live audio and/or webcast and subsequent archived replay of AngioDynamics’ presentation may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact:
AngioDynamics Inc.
Caitlin Stefanik
(518) 795-1418
[email protected]
